Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

360 ARTÍCULOS , VIENDO DEL 346 AL 360

Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim

Weinreb O, Mandel S, Bar-Am O, Amit T.

J Neural Transm (Vienna). 2011 Mar;118(3):479-92. doi: 10.1007/s00702-011-0597-6. Epub 2011 Mar 1.

Metal ions, Alzheimer's disease and chelation therapy

Budimir A.

Acta Pharm. 2011 Mar;61(1):1-14. doi: 10.2478/v10007-011-0006-6.

Correlates of care relationship mutuality among carers of people with Alzheimer's and Parkinson's disease

Shim B, Landerman LR, Davis LL.

J Adv Nurs. 2011 Aug;67(8):1729-38. doi: 10.1111/j.1365-2648.2011.05618.x. Epub 2011 Apr 4.

Deep brain stimulation emerging indications

Tierney TS, Sankar T, Lozano AM.

Prog Brain Res. 2011;194:83-95. doi: 10.1016/B978-0-444-53815-4.00015-7.

Therapeutic intervention at cellular quality control systems in Alzheimer's and Parkinson's diseases

Arduino DM, Esteves AR, Silva DF, Martins-Branco D, Santos D, Pimentel DF, Cardoso SM.

Curr Pharm Des. 2011;17(31):3446-59. doi: 10.2174/138161211798072481.

Targeting HDACs: a promising therapy for Alzheimer's disease

Xu K, Dai XL, Huang HC, Jiang ZF.

Oxid Med Cell Longev. 2011;2011:143269. doi: 10.1155/2011/143269. Epub 2011 Sep 20.

Multimodal drugs and their future for Alzheimer's and Parkinson's disease

Van der Schyf CJ, Geldenhuys WJ.

Int Rev Neurobiol. 2011;100:107-25. doi: 10.1016/B978-0-12-386467-3.00006-6.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

O'Brien JT, Burns A; BAP Dementia Consensus Group.

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547. Epub 2010 Nov 18.

Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation

Miller EA, Schneider LS, Rosenheck RA.

Int Psychogeriatr. 2011 Feb;23(1):44-53. doi: 10.1017/S1041610210000244. Epub 2010 Mar 10.

Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment

Wattmo C, Wallin AK, Londos E, Minthon L.

Gerontologist. 2011 Feb;51(1):17-27. doi: 10.1093/geront/gnq050. Epub 2010 Jun 20.

Improved language performance in Alzheimer disease following brain stimulation

Cotelli M, Calabria M, Manenti R, Rosini S, Zanetti O, Cappa SF, Miniussi C.

J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):794-7. doi: 10.1136/jnnp.2009.197848. Epub 2010 Jun 23.

Reliability and validity of the Norwegian version of the Brief Agitation Rating Scale (BARS) in dementia

Sommer OH, Engedal K.

Aging Ment Health. 2011 Mar;15(2):252-8. doi: 10.1080/13607863.2010.519318. Epub 2010 Dec 6.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.

Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.

Biomarkers for Alzheimer's disease therapeutic trials

Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group.

Prog Neurobiol. 2011 Dec;95(4):579-93. doi: 10.1016/j.pneurobio.2010.11.005. Epub 2010 Dec 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias